Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-optimized CSTB
Abstract:
The present disclosure provides methods and compositions for the treatment of diseases and genetic disorders linked to CSTB loss and/or misfunction. The methods and compositions of the present disclosure include rAAV vectors and rAAV viral vectors comprising transgene nucleic acid molecules encoding CSTB polypeptides.
Information query
Patent Agency Ranking
0/0